Narix Pharmaceuticals Private Limited

Bufedil (Buflomedil) Tablet Alpha-Adrenergic Blocker for Peripheral Vascular Insufficiency Narix Pharmaceuticals Narix Pharmaceuticals manufactures Buflomedil Tablets, an alpha-adrenergic receptor blocker with additional calcium channel blocking properties � used for peripheral circulatory disorders and chronic venous insufficiency. Key Therapeutic Uses: � Peripheral arterial occlusive disease � Raynaud's phenomenon � Chronic venous insufficiency � Cerebral circulatory insufficiency � Trophic ulcers from peripheral vascular disease Available Strengths: 150 mg 300 mg Product Highlights: � Alpha-blocker + calcium channel blocker dual action � WHO-GMP, DCGI approved � Widely used in India for peripheral vascular conditions � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #BufflomedilTablet #BufedilGeneric #AlphaBlockerVasodilator #PeripheralVascular #ChronicVenousInsufficiency #BufflomedilManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine